Catalyst Wire Dossier Catalyst Wire Dossier

CTX-4430

· Celtaxsys, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CTX-4430, covering 2013-09-10 to 2019-07-25. Get the full timeline:

Most recent: Clinical Trial Update: EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients [Phase 2]

See pricing